Elsevier’s 2026 Intravenous Medications - Elsevier E-Book on VitalSource, 42nd Edition

by Shelly Rainforth Collins, PharmD, BCGP

Elsevier eBook on VitalSource

ISBN: 9780443269615

Publication Date: 06-23-2025

Page Count: 1360

Imprint: Elsevier

List Price: $46.99

Was $46.99

Now $41.35

Or $0.00 with a valid access code

**Selected for 2025 Doody’s Core Titles® with "Essential Purchase" designation in Medical/Surgical**

Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2026 edition are 8 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.

Related Products
- 42nd Edition
  Evolve Resources for Elsevier’s 2026 Intravenous Medications
  Resources
  
  ISBN: 9780443269639
Key Features
- Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference
- Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more
- Additional drug monographs are provided on the Evolve website
- Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks
- Blue-screened text calls attention to special circumstances not covered by Black Box Warnings
- Dosage and dilution charts within monographs provide quick summaries of essential clinical information
- Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients
- Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds
- Spiral binding allows the book to lie flat, leaving your hands free to perform other tasks.
- NEW! Drug monographs for 8 newly approved drugs by the FDA include the most current information
- NEW! Updates on drug uses, interactions, precautions, alerts, and more are included throughout the guide to reflect changes to existing medications
- NEW! Best practices guidelines for the preparation and administration of injectable drugs are provided from the National Coalition for IV Push Safety
Contents

Evolve Website Information
General Dilution Charts
How to Use This Book
Preface
Format and Content of Intravenous Medications
Key to Abbreviations
Important IV Therapy Facts
Resources
Preparation and Administration of Injectable Drugs
IV Drugs

Appendix
A: Recommendations for the Safe Use and Handling of Cytotoxic Drugs
B: FDA Pregnancy Categories
C: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE)
D: Information for Patients Receiving Immunosuppressive Agents
E: Recently Approved Drugs
Authors

Shelly Rainforth Collins, PharmD, BCGP, President, Drug Information Consultants, Chesapeake, Virginia, USA
Accessibility
- Ways of Reading
  - The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
  - This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
  - No information about nonvisual reading is available
- Conformance
  - For detailed accessibility information, see Elsevier's website at https://www.elsevier.com/about/accessibility
  - For queries regarding accessibility information, contact [email protected]
  - The publication was certified on 18-11-2025
- Navigation
  - Table of contents to all chapters of the text via links
- Rich Content
  - No information is available
- Hazards
  - No information is available
- Product Content
  - No information is available
- Legal Considerations
  - No information is available
- Additional Accessibility Information
  - For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
  - E-publication includes basic navigation (usually less detailed than TOC-based navigation)
  - Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
  - All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
  - The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.